2160 — MicroPort CardioFlow Medtech Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMid CapSucker Stock
- HK$4.87bn
- HK$2.68bn
- CNY251.03m
Annual cashflow statement for MicroPort CardioFlow Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -60.3 | -145 | -398 | -183 | -451 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.84 | 18.7 | 249 | 24.4 | 170 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14.6 | -32.7 | 15.4 | -46.6 | 17 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -70.2 | -143 | -110 | -162 | -183 |
Capital Expenditures | -65.5 | -48.7 | -58.2 | -108 | -49.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -75.4 | -6.97 | 1.8 | -329 | -131 |
Acquisition of Business | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -141 | -55.7 | -56.4 | -437 | -180 |
Financing Cash Flow Items | 96.1 | -476 | -2.73 | -3.03 | 1.09 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 172 | 263 | 676 | 2,226 | -136 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -39.5 | 58.8 | 503 | 1,599 | -345 |